Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT) Share Price

Price 225.00p on 27-03-2025 at 17:30:01
Change -4.00p -1.74%
Buy 230.00p
Sell 220.00p
Buy / Sell MXCT Shares
Last Trade: Unknown 4,984.00 at 226.00p
Day's Volume: 57,500
Last Close: 226.00p
Open: 230.00p
ISIN: US57777K1060
Day's Range 226.00p - 235.00p
52wk Range: 223.00p - 405.00p
Market Capitalisation: £240m
VWAP: 228.64971p
Shares in Issue: 106m

MaxCyte (MXCT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 4,984 226.00p OTC Trade
17:08:11 - 27-Mar-25
Buy* 4,000 230.00p Suspected BUY Trade
16:40:37 - 27-Mar-25
Buy* 4,000 226.00p Suspected BUY Trade
16:35:21 - 27-Mar-25
Buy* 220 226.90p Ordinary
16:23:09 - 27-Mar-25
Buy* 714 227.50p Ordinary
16:04:42 - 27-Mar-25
Sell* 330 222.00p Ordinary
15:56:58 - 27-Mar-25
Sell* 507 216.65p Ordinary
15:31:46 - 27-Mar-25
Buy* 2,300 225.00p Ordinary
14:52:23 - 27-Mar-25
Unknown* -230 225.00p Ordinary
Correction
14:52:23 - 27-Mar-25
Buy* 230 225.00p Ordinary
14:52:23 - 27-Mar-25
See more MaxCyte trades

MaxCyte (MXCT) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Mar 2025 (Thu) 230.00 235.00 226.00 226.00 57,500
26th Mar 2025 (Wed) 240.00 230.00 230.00 230.00 9,306
25th Mar 2025 (Tue) 243.00 243.00 240.00 240.00 24
24th Mar 2025 (Mon) 242.00 243.00 240.00 243.00 19,496
21st Mar 2025 (Fri) 251.00 256.00 242.00 256.00 18,305
20th Mar 2025 (Thu) 246.00 251.00 246.00 251.00 2,054
19th Mar 2025 (Wed) 250.00 250.00 246.00 246.00 5,299
18th Mar 2025 (Tue) 250.00 250.00 250.00 250.00 118,531
17th Mar 2025 (Mon) 250.00 250.00 250.00 250.00 70,325
14th Mar 2025 (Fri) 241.00 246.00 246.00 246.00 140,094
13th Mar 2025 (Thu) 242.00 244.00 226.00 226.00 20,328
12th Mar 2025 (Wed) 259.00 245.00 230.00 230.00 93,242
11th Mar 2025 (Tue) 266.00 266.00 265.00 265.00 10,941
10th Mar 2025 (Mon) 272.00 264.00 264.00 264.00 23,670
7th Mar 2025 (Fri) 274.00 274.00 272.00 272.00 13,091
6th Mar 2025 (Thu) 277.00 277.00 274.00 274.00 10,022
5th Mar 2025 (Wed) 268.00 270.00 267.00 269.00 68,931
4th Mar 2025 (Tue) 268.00 270.00 260.00 262.00 247
3rd Mar 2025 (Mon) 260.00 268.00 260.00 268.00 5,794
28th Feb 2025 (Fri) 271.00 271.00 264.00 264.00 29,582
27th Feb 2025 (Thu) 286.00 286.00 271.00 271.00 11,221
See more MaxCyte price history

MaxCyte (MXCT) Regulatory News

Date Source Headline
26th Mar 2025 10:14 am RNS Correction: Vesting of RSUs and PDMR Dealing
26th Mar 2025 7:00 am RNS Vesting of RSUs and PDMR Dealing
25th Mar 2025 10:30 am RNS Holding(s) in Company
25th Mar 2025 10:28 am RNS Holding(s) in Company
25th Mar 2025 10:26 am RNS Holding(s) in Company
25th Mar 2025 10:22 am RNS Holding(s) in Company
24th Mar 2025 9:06 am RNS Grant of Options, RSUs and PSUs and PDMR Dealing
19th Mar 2025 2:07 pm RNS Holding(s) in Company
12th Mar 2025 7:01 am RNS Filing of Form 10-K for FY ended December 31, 2024
12th Mar 2025 7:00 am RNS Q4 & FY 2024 Financial Results
See more MaxCyte regulatory news

MaxCyte (MXCT) Share News

LONDON BRIEFING: Legal & General announces buyback after profit hike

12th Mar 2025 07:55

(Alliance News) - London's FTSE 100 is called to open higher, shaking off mixed trade in Asia and another decline in New York. Read More

MaxCyte reports wider loss, forecasts revenue growth in 2025

12th Mar 2025 07:23

(Alliance News) - MaxCyte Inc on Tuesday said its annual loss widened amid higher costs and falling revenue, but it remains optimistic about growth prospects for 2025. Read More

UK earnings, trading statements calendar - next 7 days

4th Mar 2025 15:12

Read More

MaxCyte partners with TG Therapeutics on autoimmune cell therapy

12th Feb 2025 09:30

(Alliance News) - MaxCyte Inc on Wednesday said it has signed a strategic platform licence with TG Therapeutics Inc to develop its autoimmune cell therapy. Read More

MaxCyte buys gene therapy analytics firm SeQure Dx

30th Jan 2025 13:55

(Alliance News) - MaxCyte Inc on Thursday said it has acquired SeQure Dx Inc, as it looks to improve its gene therapy testing process. Read More

See more MaxCyte news
FTSE 100 Latest
Value8,666.12
Change-23.47

Login to your account

Forgot Password?

Not Registered